DE202007016505U1 - Re-Vital Kapseln für Männer - Google Patents

Re-Vital Kapseln für Männer Download PDF

Info

Publication number
DE202007016505U1
DE202007016505U1 DE202007016505U DE202007016505U DE202007016505U1 DE 202007016505 U1 DE202007016505 U1 DE 202007016505U1 DE 202007016505 U DE202007016505 U DE 202007016505U DE 202007016505 U DE202007016505 U DE 202007016505U DE 202007016505 U1 DE202007016505 U1 DE 202007016505U1
Authority
DE
Germany
Prior art keywords
capsules
men
vital
maca
taurine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE202007016505U
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ROEPER SIYKA
Roper Siyka Dr
Original Assignee
ROEPER SIYKA
Roper Siyka Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ROEPER SIYKA, Roper Siyka Dr filed Critical ROEPER SIYKA
Priority to DE202007016505U priority Critical patent/DE202007016505U1/de
Publication of DE202007016505U1 publication Critical patent/DE202007016505U1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"Re-Vital Kapseln für Männer" dadurch gekennzeichnet, dass sie sich aus einer Wirkstoffkombination von L-Arginin, Maca, Taurin und Austernextrakt in folgendem Verhältnis zusammensetzen:
400 mg L-Arginin
60 mg Maca
50 mg Taurin
17 mg Austernextrakt

Description

Kapseln zum Einnehmen mit (je Kapsel)
  • 400 mg L-Arginin
  • 60 mg Maca
  • 50 mg Taurin
  • 17 mg Austernextrakt

Claims (1)

  1. "Re-Vital Kapseln für Männer" dadurch gekennzeichnet, dass sie sich aus einer Wirkstoffkombination von L-Arginin, Maca, Taurin und Austernextrakt in folgendem Verhältnis zusammensetzen: 400 mg L-Arginin 60 mg Maca 50 mg Taurin 17 mg Austernextrakt
DE202007016505U 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer Expired - Lifetime DE202007016505U1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE202007016505U DE202007016505U1 (de) 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE202007016505U DE202007016505U1 (de) 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer

Publications (1)

Publication Number Publication Date
DE202007016505U1 true DE202007016505U1 (de) 2008-02-14

Family

ID=39079271

Family Applications (1)

Application Number Title Priority Date Filing Date
DE202007016505U Expired - Lifetime DE202007016505U1 (de) 2007-11-26 2007-11-26 Re-Vital Kapseln für Männer

Country Status (1)

Country Link
DE (1) DE202007016505U1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362685A (zh) * 2011-10-24 2012-02-29 浙江省医学科学院 一种玛咖复方饮料及其制备方法
CN103445165A (zh) * 2013-09-04 2013-12-18 百丽晨（上海）生物科技有限公司 一种用于改善亚健康状态的产品及其组合物
CN103734740A (zh) * 2013-12-26 2014-04-23 永安康健药业（武汉）有限公司 具机能调理作用的玛咖复方保健食品及制备方法
CN104905243A (zh) * 2015-01-06 2015-09-16 江苏丰颂生物科技有限公司 一种具有抗疲劳功能的玛咖生蚝组合物及其制备方法

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102362685A (zh) * 2011-10-24 2012-02-29 浙江省医学科学院 一种玛咖复方饮料及其制备方法
CN102362685B (zh) * 2011-10-24 2012-10-17 浙江省医学科学院 一种玛咖复方饮料及其制备方法
CN103445165A (zh) * 2013-09-04 2013-12-18 百丽晨（上海）生物科技有限公司 一种用于改善亚健康状态的产品及其组合物
CN103734740A (zh) * 2013-12-26 2014-04-23 永安康健药业（武汉）有限公司 具机能调理作用的玛咖复方保健食品及制备方法
CN104905243A (zh) * 2015-01-06 2015-09-16 江苏丰颂生物科技有限公司 一种具有抗疲劳功能的玛咖生蚝组合物及其制备方法

Similar Documents

Publication Publication Date Title
IL256247B (en) Actin-actrii antagonists and uses to increase red blood cell levels
IL185381A0 (en) Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
IL194699A (en) Tetrahydropridridines, preparations containing them and uses in the preparation of drugs
MY148723A (en) Use of pinolenic acid for the treatment of obesity
IL183360A (en) 12-aryl prostaglandin analogs, compositions comprising them and their use in the preparation of medicaments
EP1981534A4 (de) Indolamin-2,3-dioxygenase-wege bei der erzeugung regulatorischer t-zellen
EP2135320A4 (de) Sekundärbatterie mit ternären eutektischen gemischen und herstellungsverfahren dafür
EP1924649A4 (de) Elektrolyt, umfassend eine eutektische mischung, und elektrochemische vorrichtung damit
PL1871277T3 (pl) Implant dentystyczny, elementy do połączenia z implantem dentystycznym oraz wewnętrzne połączenie pomiędzy implantem dentystycznym a każdym elementem
IL188732A (en) Use of ibuprofen and pamotidine for drug preparation
IL199265A (en) Oxindol derivatives are converted and used to make a drug
HK1138589A1 (en) Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors
EP1972251A4 (de) Kapselbehälter und verabreichungsverfahren damit
PL2068637T3 (pl) Składnik mleczarski wzbogacony w lipidy polarne i jego zastosowanie
WO2009048148A1 (ja) シトルリンおよびアルギニンを含有する即効性血中アルギニン濃度上昇型経口剤
IL195821A (en) Derivatives 5 (6h), 7- Dioxo-6- (4-Methylphiprazine-1-Il) -11,10,9,8,7,5-Hexhydrocyclopent [g] phenyl / pyrido [b [pyrrolo [4,3- e] Andol, pharmaceutical preparations containing them and their use in the preparation of medicines
HK1108927A1 (en) Sheets to be used in filters, masks and so on having bactericidal effect
EP1916251A4 (de) Erianinsalze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
DE202007016505U1 (de) Re-Vital Kapseln für Männer
GB0915391D0 (en) Tonic and food supplement comprising aloe vera and honey
HK1128154A1 (en) Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
IL199168A0 (en) Indolizine derivatives and the use thereof as antidiabetics
HK1120436A1 (en) Hexosylceramides as adjuvants and their uses in pharmaceutical compositions
EP1783115A4 (de) Arylaminketone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die sie enthalten und deren anwendung
GB0610836D0 (en) The preparation of multipotent stem cells and the use thereof

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20080320

R150 Utility model maintained after payment of first maintenance fee after three years

Effective date: 20101210

R157 Lapse of ip right after 6 years

Effective date: 20140603